Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 238
Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis
Julien Riou, Radoslaw Panczak, Christian L. Althaus, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 9, pp. e683-e691
Open Access | Times Cited: 116
Insights into household transmission of SARS-CoV-2 from a population-based serological survey
Qifang Bi, Justin Lessler, Isabella Eckerle, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
Antonio Leidi, Flora Koegler, Roxane Dumont, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 4, pp. 622-629
Open Access | Times Cited: 70
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study
María‐Eugenia Zaballa, Javier Perez‐Saez, Carlos de Mestral, et al.
The Lancet Regional Health - Europe (2022) Vol. 24, pp. 100547-100547
Open Access | Times Cited: 41
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021
Silvia Stringhini, María‐Eugenia Zaballa, Nick Pullen, et al.
Eurosurveillance (2021) Vol. 26, Iss. 43
Open Access | Times Cited: 54
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada
Kate Zinszer, Britt McKinnon, Noémie Bourque, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2135975-e2135975
Open Access | Times Cited: 44
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland
Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 40
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents
Roxane Dumont, Viviane Richard, Elsa Lorthe, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) study
Darryl P. Leong, Mark Loeb, Prem Mony, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
Venera Tomaselli, Pietro Ferrara, Giulio Giacomo Cantone, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 6, pp. 1617-1630
Open Access | Times Cited: 13
Immunogenicity after CoronaVac vaccination
Eda Çelik Güzel, Aliye Çelikkol, Berna Erdal, et al.
Revista da Associação Médica Brasileira (2021) Vol. 67, Iss. 10, pp. 1403-1408
Open Access | Times Cited: 16
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
Stefano Tancredi, Arnaud Chioléro, Cornelia Wagner, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1453-1465
Open Access | Times Cited: 5
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
Clémentine Metzger, Taylor Leroy, Agathe Bochnakian, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0269104-e0269104
Open Access | Times Cited: 5
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Alessia Raineri, Thomas Radtke, Sonja Rueegg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Tobacco use and risk of COVID-19 infection in the Finnish general population
Sebastián Peña, Katja Ilmarinen, Laura Kestilä, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario
Mary Aglipay, Jeffrey C. Kwong, Karen Colwill, et al.
Can J Public Health (2024) Vol. 115, Iss. 6, pp. 913-923
Closed Access | Times Cited: 1
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland
Hugo-Alejandro Santa-Ramírez, Ania Wisniak, Nick Pullen, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Higher Infection Risk among Health Care Workers and Lower Risk among Smokers Persistent across SARS-CoV-2 Waves—Longitudinal Results from the Population-Based TiKoCo Seroprevalence Study
Felix Günther, Sebastian Einhauser, David Peterhoff, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 24, pp. 16996-16996
Open Access | Times Cited: 6
Seroprevalence of Anti-SARS-CoV-2 Remained Extremely Low in Taiwan Until the Vaccination Program Was Implemented
Yun‐Yuan Chen, Minhui Yang, Jou-Zhen Lai, et al.
Open Forum Infectious Diseases (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study
Ania Wisniak, Lakshmi Krishna Menon, Roxane Dumont, et al.
Viruses (2021) Vol. 14, Iss. 1, pp. 43-43
Open Access | Times Cited: 8
Associations between Depression and Self-Reported COVID-19 Symptoms among Adults: Results from Two Population-Based Seroprevalence Studies in Switzerland
Giovanni Piumatti, Rebecca Amati, Aude Richard, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 24, pp. 16696-16696
Open Access | Times Cited: 5
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020
Aisling Vaughan, Erika Duffell, Gudrun Freidl, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e064240-e064240
Open Access | Times Cited: 2
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data
Harlan Campbell, Paul Gustafson
Epidemiology and Infection (2021) Vol. 149
Open Access | Times Cited: 6
Seroprevalence of SARS-CoV-2 antibodies in the county town of Slovakia – a pilot study from the Trencin city
Ivana Kajanová, Katarina Grossmannova, Lenka Jelenska, et al.
Acta Virologica (2022) Vol. 66, Iss. 03, pp. 228-237
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top